The Benign Mesonephroma Market is an emerging segment within the rare oncology and gynecological tumor landscape. Although rare, benign mesonephroma (also known as Wolffian adnexal tumor) is gaining clinical and research attention due to improved diagnostic imaging, advancements in histopathology, and the expansion of precision oncology. The market size is projected to...